Medicine recalls
|
| |
| Canada: Recall: PMS-Duloxetine 30 mg: Exceeds acceptable interim limit for N-nitroso-duloxetine (NDLX) |
| |
Health Canada announces that Pharmascience Inc. is recalling one lot of PMS-Duloxetine 30 mg Delayed Release Capsules - 100 capsules (lot number 646038) from retailers because the affected lot exceeds the interim acceptable limit for N-nitroso-duloxetine (NDLX).
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/pms-duloxetine-30-mg-exceeds-acceptable-interim-limit-n-nitroso-duloxetine-ndlx
In Hong Kong, PMS-Duloxetine Delayed-Release Capsules 30mg (HK-65446) is a pharmaceutical product registered by Trenton-Boma Ltd. The product is a prescription-only medicine. As confirmed by the company, the affected lot has not been imported into Hong Kong.
Ends/ Wednesday, April 17, 2024
Issued at HKT 15:00
|
| |
